These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy. Wood DP; Beaman A; Banerjee M; Powell I; Pontes E; Cher ML Clin Cancer Res; 1998 Sep; 4(9):2119-23. PubMed ID: 9748128 [TBL] [Abstract][Full Text] [Related]
24. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes? King CR; Presti JC; Gill H; Brooks J; Hancock SL Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):341-7. PubMed ID: 15145146 [TBL] [Abstract][Full Text] [Related]
25. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776 [TBL] [Abstract][Full Text] [Related]
28. [Treatment results of radical prostatectomy in clinical stage B and C prostate cancer: comparison of the neoadjuvant therapy group versus the surgery group; retrospective analysis of 80 cases]. Ogura Y; Sakata Y; Wakita T; Hayashi N; Hioki T; Sugimura Y Hinyokika Kiyo; 2003 Sep; 49(9):515-20. PubMed ID: 14598688 [TBL] [Abstract][Full Text] [Related]
29. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy. Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763 [TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant hormone therapy: the Canadian trials. Klotz L; Gleave M; Goldenberg SL Mol Urol; 2000; 4(3):233-7;discussion 239. PubMed ID: 11062379 [TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant hormonal therapy plus surgery for prostate cancer. The MSKCC experience. Fair WR; Scher HI Surg Oncol Clin N Am; 1997 Oct; 6(4):831-46. PubMed ID: 9309096 [TBL] [Abstract][Full Text] [Related]
32. Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer. Ryan CJ; Zelefsky MJ; Heller G; Regan K; Leibel SA; Scher HI; Kelly WK Urology; 2004 Jul; 64(1):90-4. PubMed ID: 15245942 [TBL] [Abstract][Full Text] [Related]
33. [Recent improvements and results of radical prostatectomy]. Usami M Gan To Kagaku Ryoho; 1996 Mar; 23(4):407-12. PubMed ID: 8678490 [TBL] [Abstract][Full Text] [Related]
34. Androgen deprivation with salvage surgery for radiorecurrent prostate cancer: results at 5-year followup. Garzotto M; Wajsman Z J Urol; 1998 Mar; 159(3):950-4; discussion 954-5. PubMed ID: 9474190 [TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant therapy prior to radiotherapy for clinically localized prostate cancer. Roach M Eur Urol; 1997; 32 Suppl 3():48-54. PubMed ID: 9267785 [TBL] [Abstract][Full Text] [Related]
36. [New development of endocrine therapy in prostate cancer]. Naito S Gan To Kagaku Ryoho; 1996 May; 23(6):684-8. PubMed ID: 8645018 [TBL] [Abstract][Full Text] [Related]
37. Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer. D'Amico AV; Saegaert T; Chen MH; Renshaw AA; George D; Oh W; Kantoff PW Cancer; 2002 Jul; 95(2):275-80. PubMed ID: 12124826 [TBL] [Abstract][Full Text] [Related]
38. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31. Pilepich MV; Winter K; Lawton CA; Krisch RE; Wolkov HB; Movsas B; Hug EB; Asbell SO; Grignon D Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1285-90. PubMed ID: 15817329 [TBL] [Abstract][Full Text] [Related]
39. Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects. Gleave ME; Goldenberg SL; Chin JL; Warner J; Saad F; Klotz LH; Jewett M; Kassabian V; Chetner M; Dupont C; Van Rensselaer S; J Urol; 2001 Aug; 166(2):500-6; discussion 506-7. PubMed ID: 11458055 [TBL] [Abstract][Full Text] [Related]
40. Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? Messing EM J Urol; 2003 Nov; 170(5):1955; author reply 1955-6. PubMed ID: 14532828 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]